Vanguard Group’s ALX Oncology ALXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $664K | Sell |
|
|||||
|
2025
Q1 | $1.15M | Sell |
|
|||||
|
2024
Q4 | $3.15M | Buy |
|
|||||
|
2024
Q3 | $3.43M | Buy |
|
|||||
|
2024
Q2 | $10.4M | Buy |
|
|||||
|
2024
Q1 | $17.5M | Buy |
|
|||||
|
2023
Q4 | $22.4M | Buy |
|
|||||
|
2023
Q3 | $4.84M | Buy |
|
|||||
|
2023
Q2 | $7.56M | Sell |
|
|||||
|
2023
Q1 | $4.68M | Sell |
|
|||||
|
2022
Q4 | $16.1M | Buy |
|
|||||
|
2022
Q3 | $13.5M | Buy |
|
|||||
|
2022
Q2 | $10.7M | Sell |
|
|||||
|
2022
Q1 | $28.3M | Sell |
|
|||||
|
2021
Q4 | $36.7M | Buy |
|
|||||
|
2021
Q3 | $124M | Buy |
|
|||||
|
2021
Q2 | $84.7M | Buy |
|
|||||
|
2021
Q1 | $100M | Buy |
|
|||||
|
2020
Q4 | $76.1M | Buy |
|
|||||
|
2020
Q3 | $24.4M | Buy |
|